## Most Common Cause of TB Treatment Failure **Key Point:** Inadequate drug compliance and irregular intake is the single most common cause of treatment failure in tuberculosis, accounting for approximately 60–70% of all treatment failures in resource-limited settings like India. ### Epidemiology of Treatment Failure In India, where TB burden is high and healthcare infrastructure is variable, non-adherence to the full 6-month regimen is the predominant reason for: - Persistent sputum positivity beyond 2 months - Microbiological failure - Development of secondary drug resistance **Clinical Pearl:** The DOTS (Directly Observed Therapy, Short-course) strategy was specifically designed to overcome this challenge by ensuring supervised administration of anti-TB drugs. ### Why Compliance Matters **High-Yield:** Irregular intake of even first-line drugs (HRZE) allows: 1. Incomplete bacterial killing 2. Selection pressure for resistant mutants 3. Prolonged infectivity and transmission 4. Relapse and recurrence ### Comparison with Other Causes | Cause | Frequency | Notes | |-------|-----------|-------| | Non-compliance | 60–70% | Most common; preventable with DOTS | | MDR-TB | 2–3% (primary); 10–15% (acquired) | Requires prolonged, expensive therapy | | Malabsorption | 5–10% | Seen in HIV, GI TB, chronic diarrhea | | HIV co-infection | 5–8% | Increases risk of treatment failure and immune reconstitution | **Mnemonic: FAIL** — **F**irst-line drugs (adequate), **A**dherence (supervised), **I**mmune status (assess), **L**aboratory confirmation (baseline and follow-up). ### Clinical Management Approach When treatment failure is suspected: 1. Confirm continued sputum positivity at 2 months 2. Assess compliance history 3. Rule out malabsorption (HIV, GI TB) 4. Send sputum for drug sensitivity testing (DST) 5. Reinforce DOTS and counseling [cite:Harrison 21e Ch 205]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.